Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

70.35 -0.13 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
31 32 Next >
Wall Street Believes These High-Profile Stock-Split Stocks Can Lose Up to 91% of Their Value
The low-water price targets provided by select analysts and Wall Street institutions suggest these widely owned stock-split stocks could plunge. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Nvidia And This AI Stock Lead 5 Names Near Buy Points
Nvidia has soared this year. Now its tight range has created a new buy point. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
2 Growth Stocks That Could Double in 5 Years
They could deliver excellent returns well beyond that. 
Via The Motley Fool
A Look Into DexCom Inc's Price Over Earnings
Via Benzinga
Peering Into DexCom's Recent Short Interest
Via Benzinga
DexCom Unusual Options Activity For June 26
Via Benzinga
Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Just 8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens
This elite eight meet long-term growth criteria for sales and earnings. 
Via Investor's Business Daily
Dexcom G7 Continuous Glucose Monitoring System Gets Regulatory Nod From Health Canada
DexCom, Inc.'s (NASDAQ: DXCM) next-generation  
Via Benzinga
Where DexCom Stands With Analysts
Via Benzinga
DexCom Revises 2025 Outlook, Announces New Product For Diabetics
DexCom Inc (NASDAQ: DXCM) disclosed the 2025 financial targets revision at  
Via Benzinga
DexCom Unusual Options Activity
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $74,000 Today
Via Benzinga
1 Stock-Split Stock to Buy Hand Over Fist in July and 1 to Avoid Like the Plague
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage, there's one phenomenal value and another top performer that's arguably never been this pricey. 
Via The Motley Fool
Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians
From Dexcom, Inc.
Via Business Wire
Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers
Via Benzinga
Elliott Wave Technical Analysis: DexCom Inc, June 20
Looking for a correction in wave (ii) as we seem to be extending higher into wave {iii}. We successfully broke the previous top of wave {i} to confirm further upside. 
Via Talk Markets
Elliott Wave Technical Analysis: Dexcom Inc., Wednesday, June 14
With DexCom Inc., we are looking at the resumption of the uptrend as we expected in the last forecast. We finally broke the top of wave {i} and we are now looking for upside into wave (C). 
Via Talk Markets
Elliott Wave Technical Analysis: DexCom Inc. - Thursday, June 8
Looking for upside continuation into wave 3. 
Via Talk Markets
Friday's ETF Winners And Losers: Large-Cap Fund Flows - VOO and SPY Add More Than $1.5 Billion Each
We performed a screening of large-cap ETFs - defined as having Assets Under Management (AUM) over $10 billion - to determine what funds had the largest change in net assets on the week, according to... 
Via Benzinga
Elliott Wave Technical Analysis: DexCom Inc. - Thursday, June 29
Looking for upside into wave {iii} as long as we don’t break the bottom of wave {ii}. 
Via Talk Markets
Dexcom, A Top 2% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market
The company makes continuous glucose monitors for patients with diabetes. 
Via Investor's Business Daily
Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More
From Dexcom, Inc.
Via Business Wire
Dexcom Updates Long-Range Financial Targets
From DexCom, Inc.
Via Business Wire
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
DarioHealth is an AI-Powered Digital Therapeutics Play
DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dexcom to Host Investor Day on June 23, 2023
From DexCom, Inc.
Via Business Wire
Have $1,500? 2 Top Growth Stocks to Buy and Hold for the Long Haul
Fears of a bear market shouldn't deter long-term investors from quality businesses. 
Via The Motley Fool
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.